FindTrial
Sign In

The use of indocyanine green fluorescent angiography to guide the surgical treatment of Crohn's disease

The use of indocyanine green fluorescent angiography to guide the surgical treatment of Crohn's disease: a single-center randomized single-blind cohort study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012532
Enrollment
Unknown
Registered
2017-09-01
Start date
2017-08-23
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

Intervention group:Indocyanine green fluorescent angiography
control group:Physiological saline

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Voluntarily accepted and signed informed consent; aged 18-70 years old, male or female; able to communicate with the researchers and complete the experimental process; clinically diagnosed as CD, and have surgical indications of patients.

Exclusion criteria

Exclusion criteria: Obvious allergies, or allergies to a variety of drugs; combined with severe cardiopulmonary dysfunction, renal failure, acute cardiovascular and cerebrovascular accident patients; patients with malignant tumor recurrence or metastasis signs; clinically diagnosed CD, but no surgical treatment Of patients.

Design outcomes

Primary

MeasureTime frame
Intestinal fistula;—

Secondary

MeasureTime frame
Disease recurrence;—

Countries

China

Contacts

Public ContactYousheng Li

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

gisurgery@qq.com+86 18019790260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026